Progressive multifocal leukoencephalopathy in AIDS: Are there any MR findings useful to patient management and predictive of patient survival?

M. Judith Post, Constantin Yiannoutsos, David Simpson, John Booss, David B. Clifford, Bruce Cohen, Justin C. McArthur, Colin D. Hall

Research output: Contribution to journalArticle

137 Citations (Scopus)

Abstract

BACKGROUND AND PURPOSE: While MR findings in progressive multifocal leukoencephalopathy (PML) have been described previously, usually in retrospective studies with limited sample size, what has not been well addressed is whether any are predictive of longer survival. Our participation in a large prospective clinical trial of AIDS patients with biopsy-proved PML and MR correlation allowed us to test our hypothesis that certain MR features could be found favorable to patient survival. METHODS: The patient cohort derived from a randomized multicenter clinical trial of cytosine arabinoside for PML. Pretreatment T1- and T2-weighted noncontrast images (n = 48) and T1- weighted contrast-enhanced images (n = 45) of 48 HIV-positive patients with a PML tissue diagnosis as well as the follow-up images in 15 patients were reviewed to determine signal abnormalities, lesion location and size, and the presence or absence of mass effect, contrast enhancement, and atrophy, and to ascertain the frequency of these findings. A statistical analysis was performed to determine if any MR abnormalities, either at baseline or at follow-up, were predictive of patient survival. RESULTS: No MR abnormalities either on univariate or multivariate analysis significantly correlated with patient survival, with the exception of mass effect, which was significantly associated with shorter survival. The mass effect, however, always minimal, was infrequent (five of 48). More severe degrees of cortical atrophy and ventricular dilatation, lesion location and size, and other MR variables were not predictive of outcome. CONCLUSION: Except for mass effect, we found no MR findings predictive of the risk of death in patients with PML. The mass effect, however, was so infrequent and minimal that it was not a useful MR prognostic sign.

Original languageEnglish
Pages (from-to)1896-1906
Number of pages11
JournalAmerican Journal of Neuroradiology
Volume20
Issue number10
StatePublished - Nov 30 1999

Fingerprint

Progressive Multifocal Leukoencephalopathy
Acquired Immunodeficiency Syndrome
Survival
Atrophy
Cytarabine
Sample Size
Multicenter Studies
Dilatation
Multivariate Analysis
Randomized Controlled Trials
Retrospective Studies
Clinical Trials
HIV
Biopsy

ASJC Scopus subject areas

  • Clinical Neurology
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Judith Post, M., Yiannoutsos, C., Simpson, D., Booss, J., Clifford, D. B., Cohen, B., ... Hall, C. D. (1999). Progressive multifocal leukoencephalopathy in AIDS: Are there any MR findings useful to patient management and predictive of patient survival? American Journal of Neuroradiology, 20(10), 1896-1906.

Progressive multifocal leukoencephalopathy in AIDS : Are there any MR findings useful to patient management and predictive of patient survival? / Judith Post, M.; Yiannoutsos, Constantin; Simpson, David; Booss, John; Clifford, David B.; Cohen, Bruce; McArthur, Justin C.; Hall, Colin D.

In: American Journal of Neuroradiology, Vol. 20, No. 10, 30.11.1999, p. 1896-1906.

Research output: Contribution to journalArticle

Judith Post, M, Yiannoutsos, C, Simpson, D, Booss, J, Clifford, DB, Cohen, B, McArthur, JC & Hall, CD 1999, 'Progressive multifocal leukoencephalopathy in AIDS: Are there any MR findings useful to patient management and predictive of patient survival?', American Journal of Neuroradiology, vol. 20, no. 10, pp. 1896-1906.
Judith Post, M. ; Yiannoutsos, Constantin ; Simpson, David ; Booss, John ; Clifford, David B. ; Cohen, Bruce ; McArthur, Justin C. ; Hall, Colin D. / Progressive multifocal leukoencephalopathy in AIDS : Are there any MR findings useful to patient management and predictive of patient survival?. In: American Journal of Neuroradiology. 1999 ; Vol. 20, No. 10. pp. 1896-1906.
@article{8eadfee34f6c42759b979f4d021b5a8f,
title = "Progressive multifocal leukoencephalopathy in AIDS: Are there any MR findings useful to patient management and predictive of patient survival?",
abstract = "BACKGROUND AND PURPOSE: While MR findings in progressive multifocal leukoencephalopathy (PML) have been described previously, usually in retrospective studies with limited sample size, what has not been well addressed is whether any are predictive of longer survival. Our participation in a large prospective clinical trial of AIDS patients with biopsy-proved PML and MR correlation allowed us to test our hypothesis that certain MR features could be found favorable to patient survival. METHODS: The patient cohort derived from a randomized multicenter clinical trial of cytosine arabinoside for PML. Pretreatment T1- and T2-weighted noncontrast images (n = 48) and T1- weighted contrast-enhanced images (n = 45) of 48 HIV-positive patients with a PML tissue diagnosis as well as the follow-up images in 15 patients were reviewed to determine signal abnormalities, lesion location and size, and the presence or absence of mass effect, contrast enhancement, and atrophy, and to ascertain the frequency of these findings. A statistical analysis was performed to determine if any MR abnormalities, either at baseline or at follow-up, were predictive of patient survival. RESULTS: No MR abnormalities either on univariate or multivariate analysis significantly correlated with patient survival, with the exception of mass effect, which was significantly associated with shorter survival. The mass effect, however, always minimal, was infrequent (five of 48). More severe degrees of cortical atrophy and ventricular dilatation, lesion location and size, and other MR variables were not predictive of outcome. CONCLUSION: Except for mass effect, we found no MR findings predictive of the risk of death in patients with PML. The mass effect, however, was so infrequent and minimal that it was not a useful MR prognostic sign.",
author = "{Judith Post}, M. and Constantin Yiannoutsos and David Simpson and John Booss and Clifford, {David B.} and Bruce Cohen and McArthur, {Justin C.} and Hall, {Colin D.}",
year = "1999",
month = "11",
day = "30",
language = "English",
volume = "20",
pages = "1896--1906",
journal = "American Journal of Neuroradiology",
issn = "0195-6108",
publisher = "American Society of Neuroradiology",
number = "10",

}

TY - JOUR

T1 - Progressive multifocal leukoencephalopathy in AIDS

T2 - Are there any MR findings useful to patient management and predictive of patient survival?

AU - Judith Post, M.

AU - Yiannoutsos, Constantin

AU - Simpson, David

AU - Booss, John

AU - Clifford, David B.

AU - Cohen, Bruce

AU - McArthur, Justin C.

AU - Hall, Colin D.

PY - 1999/11/30

Y1 - 1999/11/30

N2 - BACKGROUND AND PURPOSE: While MR findings in progressive multifocal leukoencephalopathy (PML) have been described previously, usually in retrospective studies with limited sample size, what has not been well addressed is whether any are predictive of longer survival. Our participation in a large prospective clinical trial of AIDS patients with biopsy-proved PML and MR correlation allowed us to test our hypothesis that certain MR features could be found favorable to patient survival. METHODS: The patient cohort derived from a randomized multicenter clinical trial of cytosine arabinoside for PML. Pretreatment T1- and T2-weighted noncontrast images (n = 48) and T1- weighted contrast-enhanced images (n = 45) of 48 HIV-positive patients with a PML tissue diagnosis as well as the follow-up images in 15 patients were reviewed to determine signal abnormalities, lesion location and size, and the presence or absence of mass effect, contrast enhancement, and atrophy, and to ascertain the frequency of these findings. A statistical analysis was performed to determine if any MR abnormalities, either at baseline or at follow-up, were predictive of patient survival. RESULTS: No MR abnormalities either on univariate or multivariate analysis significantly correlated with patient survival, with the exception of mass effect, which was significantly associated with shorter survival. The mass effect, however, always minimal, was infrequent (five of 48). More severe degrees of cortical atrophy and ventricular dilatation, lesion location and size, and other MR variables were not predictive of outcome. CONCLUSION: Except for mass effect, we found no MR findings predictive of the risk of death in patients with PML. The mass effect, however, was so infrequent and minimal that it was not a useful MR prognostic sign.

AB - BACKGROUND AND PURPOSE: While MR findings in progressive multifocal leukoencephalopathy (PML) have been described previously, usually in retrospective studies with limited sample size, what has not been well addressed is whether any are predictive of longer survival. Our participation in a large prospective clinical trial of AIDS patients with biopsy-proved PML and MR correlation allowed us to test our hypothesis that certain MR features could be found favorable to patient survival. METHODS: The patient cohort derived from a randomized multicenter clinical trial of cytosine arabinoside for PML. Pretreatment T1- and T2-weighted noncontrast images (n = 48) and T1- weighted contrast-enhanced images (n = 45) of 48 HIV-positive patients with a PML tissue diagnosis as well as the follow-up images in 15 patients were reviewed to determine signal abnormalities, lesion location and size, and the presence or absence of mass effect, contrast enhancement, and atrophy, and to ascertain the frequency of these findings. A statistical analysis was performed to determine if any MR abnormalities, either at baseline or at follow-up, were predictive of patient survival. RESULTS: No MR abnormalities either on univariate or multivariate analysis significantly correlated with patient survival, with the exception of mass effect, which was significantly associated with shorter survival. The mass effect, however, always minimal, was infrequent (five of 48). More severe degrees of cortical atrophy and ventricular dilatation, lesion location and size, and other MR variables were not predictive of outcome. CONCLUSION: Except for mass effect, we found no MR findings predictive of the risk of death in patients with PML. The mass effect, however, was so infrequent and minimal that it was not a useful MR prognostic sign.

UR - http://www.scopus.com/inward/record.url?scp=0344771116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344771116&partnerID=8YFLogxK

M3 - Article

C2 - 10588116

AN - SCOPUS:0344771116

VL - 20

SP - 1896

EP - 1906

JO - American Journal of Neuroradiology

JF - American Journal of Neuroradiology

SN - 0195-6108

IS - 10

ER -